Safety and Clinical Activity of MK-3475 as Initial Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Switch Maintenance With Sunitinib (S) in Advanced Non-Small Cell Lung Cancer (NSCLC): An Alliance (CALGB 30607), Randomized, Placebo-Controlled Phase 3 Trial Metastatic Non-Small Cell Lung Cancer M.A. Socinski, X. Wang, M. Baggstrom, L. Gu, T. Stinchcombe, M. Edelman, S. Baker, H. Mannuel, J. Crawford, and E. Vokes; University of Pittsburgh Cancer Institute, Pittsburgh, PA, Alliance Statistics and Data Center, Durham, NC, Washington University School of Medicine, St Louis, MO, University of North Carolina, Chapel Hill, NC, University of New Mexico Cancer Center, Albuquerque, NM, Virginia Commonwealth University, Richmond, VA, University of Maryland Greenbaum Cancer Center, Baltimore, MD, Duke Cancer Institute, Durham, PA, University of Chicago Medicine and Biological Sciences, Chicago, IL